Studies

CellWell record HH-465358

Levonorgestrel-ethinyl estradiol impairs hepatic lipid clearance to induce hypercholesterolemia via PCSK9-mediated LDLR and CD36 dysregulation.

Bing-Zhi Li; Chen-Ji Ye; Zhuo Wang; Jun-Ying Zhang; Ze-Yu Fan; Ying-Hui Huo; Xian-Wei Wang; Feng-Hua Lv

Toxicology and Applied Pharmacology ยท 2026

In plain language

In female mice, an oral contraceptive combination raised PCSK9, lowered liver LDL receptor, and increased LDL cholesterol and triglycerides, while these changes were absent in mice lacking PCSK9.

Evidence
Emerging
Design
Primary research (design unspecified)

Read it on DOI

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-465358

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.